Abstract
The effect of acetaldehyde on the transglutaminase activity in pooled normal human plasma has been investigated. In this study, 0.05, 0.2, and 0.7 ml of pooled human plasma were preincubated for 30 min. at room temperature with buffer or acetaldehyde at final concentrations of 40.6, 22.4, and 11.2 mM before being utilized for Factor XIIIa assay with fibrinogen and thrombin which had been preheated at 40°C to destroy endogenous Factor XIII/XIIIa activity. At all concentrations of acetaldehyde and all concentrations of plasma-containing Factor XIII which were employed, prolongation of both clotting time and stabilization time was observed. The 11.2 mM acetaldehyde is within the range of daily acetaldehyde production to be predicted in severe alcoholics as a consequence of imbibing alcohol. The stabilization times measured for Factor XIIIa activity appear to be the most sensitive to acetaldehyde compared to acetaldehyde effects on thrombin, Factor Xa, and fibrinogen studied earlier in this laboratory, as well as Factors II, VII, and X.
Similar content being viewed by others
References
Podolsky DK, Isselbacher KJ (1994) Alcohol-related liver disease and cirrhosis. In: Harrison’s principles of internal medicine, 13th ed. Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL (eds). McGraw-Hill, New York, pp 1483–1495
Crabb DW, Lumeng L (1989) Alcoholic liver diseases. In: Textbook of internal medicine. Kelly WN (ed). Lippincott, Philadelphia, pp 592–602
Skrzydlewska E, Worowski K (1984–1985) Influence of ethanol and acetaldehyde on blood coagulation. Rocs Akad Med Bialymst 29–30:153–162
Brecher AS (2005) The effect of acetaldehyde on plasma. In: Comprehensive handbook of alcohol related pathology. Preedy VR, Watson R (eds). Academic Press, Elsevier Science, London, pp 1223–1244
Lenehan JG, Smith K (1985) Hemostasis, 17th ed. General Diagnostics, Morris Plains, NJ, p 45
Lelbach WK (1976) Epidemology of alcoholic liver disease. In: Progress in liver diseases. Popper H, Schaffner F (eds). Grune & Stratton, New York, pp 494–515
Brecher AS, Hellman K, Basista MH (1997) A perspective on acetaldehyde concentrations and toxicity in man and animals. Alcohol 14:493–496
Brecher AS, Adamu MT (2002) Short- and long-term effects of acetaldehyde on plasma. Alcohol 26:49–53
Brecher AS, Koterba AP, Basista MH (1996) Coagulation protein function. III. Effect of acetaldehyde upon the activation of prothrombin. Alcohol 13:423–429
Brecher AS, Koterba AP, Basista MH (1996) Coagulation protein function. IV. Effect of acetaldehyde upon factor X and factor Xa, the proteins at the gateway to the common coagulation pathway. Alcohol 13:539–545
Sabol DA, Basista MH, Brecher AS, Haider K, Kleshinski J (1999) Coagulation protein function VII: diametric effects of acetaldehyde on factor VII and factor IX function. Dig Dis Sci 44:2564–2567
Basista MH, Joseph A, Smolen, S, Koterba A, Brecher AS (1994) Acetaldehyde alters coagulation protein function. Dig Dis Sci 39:2421–2425
Hatake K, Taniguchi T, Ouchi H, Sakaki N, Hishida S, Ijiri I (1990) Possible involvement of kinins in cardiovascular changes after alcohol intake. Pharmacol Biochem Behav 35:437–442
Salaspuro M (1991) Epidemiological aspects of alcohol and alcoholic liver disease, ethanol metabolism and pathogenesis of alcoholic liver injury. In: Oxford textbook of clinical hepatology. McIntyre N, Benhamov JP, Bircher J, Rizzetto M, Rodes J (eds). Oxford Press, Oxford, pp 791–810
Watanabe A, Kobayashi M, Hobara N, Nakatsukasa H, Nagashima H, Fujimoto A (1985) A report of unusually high blood ethanol and acetaldehyde levels in two surviving patients. Alcohol Clin Exp Res 9:14–16
Bordalo O, Batista A, Geraldes J, Neto F, Mascarenhas F, Leitao N, Noronha M, Silva PE (1974) Clinical correlations in alcoholic patients without manifest cirrhosis. Am J Gastroenterol 61:371–378
Braun KP, Pavlovich JG, Jones DR, Peterson CM (1997) Stable acetaldehyde adducts: structural characterization of acetaldehyde adducts of human hemoglobin N-terminal B-globin chain peptides. Alcohol Clin Exp Res 21:40–43
Lin RC, Lumeng L, Shahidi S, Kelly T, Pound DC (1990) Protein-acetaldehyde adducts in serum of alcoholic patients. Alcohol Clin Exp Res 14:438–443
Lin RC, Shahidi S, Kelly TJ, Lumeng C, Lumeng L (1993) Measurement of hemoglobin-acetaldehdye adduct in alcoholic patients. Alcohol Clin Exp Res 17:669–674
Nagata N, Nishizaki Y, Watanabe N, Tsuda M, Matsuzaki S (1998) An enzyme immune assay for serum anti-acetaldehyde adduct antibody using low-density lipoprotein adduct and its significance in alcoholic liver injury. Alcohol Clin Exp Res 22(Suppl 3):150S–155S
Nicholls RM, Fowles LF, Worrall S, de Jersey J, Wilce PA (1994) Distribution and turnover of acetaldehyde-modified proteins in liver and blood of ethanol-fed rats. Alcohol Alcohol 29:149–157
Niemela O (1999) Aldehyde-protein adducts in the liver as a result of ethanol-induced oxidative stress. Front Biosci 4:D506–D513
Niemela O, Israel Y, Mizoi Y, Fukunaga T, Eriksson CJ (1990) Hemoglobin-acetaldehyde adducts in human volunteers following acute ethanol ingestion. Alcohol Clin Exp Res 14:838–841
Niemela O, Parkkila S, Pasanen M, Iimur Y, Bradford B, Thuman RG (1998) Early alcoholic liver injury: formation of protein adducts with acetaldehyde and lipid peroxidation products, and expression of CYP2E1 and CYP3A. Alcohol Clin Exp Res 22:2118–2124
Sorrell MF, Tuma DJ (1987) The functional implications of acetaldehyde binding to cell constituents. Ann NY Acad Sci 492:50–62
Svegliati-Baroni G, Baraona E, Rosman AS, Lieber CS (1994) Collagen-acetaldehyde adducts in alcoholic and nonalcoholic liver diseases. Hepatology 20:111–118
Wickramasinghe SN, Thomas S, Hasan R (1994) Reaction of 14C-acetaldehyde with whole blood in vitro: further evidence for the formation of unstable complexes with plasma proteins and red cells. Alochol Alcohol 29:51–57
Worall S, deJersey J, Wilce PA, Seppa K, Hurme L, Sillinaukee P (1996) Relationship between alcohol intake and immunoglobulin A immunoreactivity with acetaldehyde-modified bovine serum albumin. Alcohol Clin Exp Res 20:836–840
Brecher AS, Hellman K, Dulin C Basista MH (1998) Coagulation protein function V: diminution of antithrombin III function by acetaldehyde. Dig Dis Sci 43:1746–1751
Acknowledgments
The authors express their deep appreciation to Wilfredo Pacio, M.D., and Mrs. Glenna Pool of the clinical laboratory of Wood County Hospital for generously providing the normal pooled human plasma samples utilized in this study. They further acknowledge the assistance of Dr. Nancy Boudreau of BGSU for assistance with the statistical evaluation of the data.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Suchocki, E.A., Brecher, A.S. The Effect of Acetaldehyde on Human Plasma Factor XIII Function. Dig Dis Sci 52, 3488–3492 (2007). https://doi.org/10.1007/s10620-007-9754-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-007-9754-z